Half-year report · HY
7716.TEDINET S100YULE
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥81.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥39.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥11.6bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.9bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥11.5bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥7.0bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.1bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.1bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥174.6bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥160.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥153.8bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥52.5bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥46.1bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥122.0bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥114.1bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥117.3bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥56.4bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥61.3bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥40.4bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.0bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.2bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.6bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥19.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥679m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥98.07 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.7 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.84 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥97.72 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.7 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 69.6% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.0% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥443m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥443m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥2.2bn |
| DCI Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥12.2bn |
| DCI Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥12.2bn |
| DCI Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥674m |
| Dental Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥27.4bn |
| Dental Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥27.0bn |
| Dental Productsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥443m |
| Dental Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥9.0bn |
| Industrial Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Industrial Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Industrial Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Surgical Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.9bn |
| Surgical Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.9bn |
| Surgical Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.5bn |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥47.7bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥47.2bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥443m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥12.3bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.0bn |
| DCI Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| DCI Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| DCI Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥66m |
| Dental Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥23.7bn |
| Dental Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥23.5bn |
| Dental Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| Dental Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.0bn |
| Industrial Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Industrial Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Industrial Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥306m |
| Surgical Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Surgical Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Surgical Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.2bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥39.4bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥39.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥9.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | Prior1InterimDuration | -6439803000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -18969432000 | JPY |
| Increase in short term loans payable fin cf | Prior1InterimDuration | 2002800000 | JPY |
| Increase in short term loans payable fin cf | InterimDuration | 11000000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1InterimDuration | -2000000000 | JPY |
| Decrease in short term loans payable fin cf | InterimDuration | -2681884000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1InterimDuration | 3032980000 | JPY |
| Proceeds from long term loans payable fin cf | InterimDuration | 3010618000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -1145998000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -4262151000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -2195778000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -2325452000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | -2253016000 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -2559014000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | 4741131000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -1152732000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 1092169000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -2573185000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -5515379000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 35224056000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 45964061000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 32650870000 | JPY |
| Cash and cash equivalents | InterimInstant | 40448681000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 4405996000 | JPY |
| Salaries and allowances sga | InterimDuration | 4729987000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 142295000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 165730000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DentalProductsReportableSegmentsMember | 23533425000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DCIProductsReportableSegmentsMember | 9834925000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02331-000SurgicalProductsReportableSegmentsMember | 2548870000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02331-000IndustrialProductsReportableSegmentsMember | 3272506000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 39189728000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 39189728000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DentalProductsReportableSegmentsMember | 176033000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DCIProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02331-000SurgicalProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02331-000IndustrialProductsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | 176033000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -176033000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DentalProductsReportableSegmentsMember | 23709459000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DCIProductsReportableSegmentsMember | 9834925000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02331-000SurgicalProductsReportableSegmentsMember | 2548870000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02331-000IndustrialProductsReportableSegmentsMember | 3272506000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 39365762000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -176033000 | JPY |
| Net sales | Prior1InterimDuration | 39189728000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02331-000DentalProductsReportableSegmentsMember | 8006365000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |